5,968 Shares in Entegris, Inc. (NASDAQ:ENTG) Acquired by Neo Ivy Capital Management

Neo Ivy Capital Management acquired a new position in Entegris, Inc. (NASDAQ:ENTG) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,968 shares of the semiconductor company’s stock, valued at approximately $808,000.

Other institutional investors also recently modified their holdings of the company. CANADA LIFE ASSURANCE Co grew its position in Entegris by 161.1% during the first quarter. CANADA LIFE ASSURANCE Co now owns 107,677 shares of the semiconductor company’s stock valued at $15,135,000 after acquiring an additional 66,437 shares during the last quarter. BNP Paribas bought a new position in Entegris during the first quarter valued at approximately $1,647,000. California Public Employees Retirement System grew its position in Entegris by 17.6% during the fourth quarter. California Public Employees Retirement System now owns 257,147 shares of the semiconductor company’s stock valued at $30,811,000 after acquiring an additional 38,557 shares during the last quarter. Virtu Financial LLC bought a new position in Entegris during the fourth quarter valued at approximately $892,000. Finally, Stifel Financial Corp grew its position in Entegris by 6.5% during the fourth quarter. Stifel Financial Corp now owns 122,392 shares of the semiconductor company’s stock valued at $14,665,000 after acquiring an additional 7,456 shares during the last quarter.

Entegris Stock Performance

NASDAQ ENTG traded down $3.08 during trading hours on Tuesday, hitting $111.51. The company’s stock had a trading volume of 197,030 shares, compared to its average volume of 1,549,661. Entegris, Inc. has a 12 month low of $84.13 and a 12 month high of $147.57. The company’s 50 day simple moving average is $127.33 and its two-hundred day simple moving average is $130.85. The company has a market cap of $16.81 billion, a P/E ratio of 55.09, a price-to-earnings-growth ratio of 1.27 and a beta of 1.25. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.58 and a quick ratio of 2.02.

Entegris (NASDAQ:ENTG) last released its quarterly earnings data on Wednesday, July 31st. The semiconductor company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.70 by $0.01. Entegris had a return on equity of 12.03% and a net margin of 5.61%. The company had revenue of $812.60 million during the quarter, compared to the consensus estimate of $802.43 million. During the same period last year, the company earned $0.66 EPS. Entegris’s revenue for the quarter was down 9.8% on a year-over-year basis. As a group, sell-side analysts expect that Entegris, Inc. will post 3.22 EPS for the current fiscal year.

Entegris Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 21st. Shareholders of record on Wednesday, July 31st will be paid a dividend of $0.10 per share. The ex-dividend date is Wednesday, July 31st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.36%. Entegris’s dividend payout ratio is currently 19.23%.

Insider Buying and Selling at Entegris

In other Entegris news, SVP James Anthony O’neill sold 6,761 shares of the business’s stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $133.50, for a total transaction of $902,593.50. Following the completion of the sale, the senior vice president now directly owns 13,652 shares in the company, valued at approximately $1,822,542. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, SVP James Anthony O’neill sold 6,761 shares of Entegris stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $133.50, for a total transaction of $902,593.50. Following the transaction, the senior vice president now directly owns 13,652 shares of the company’s stock, valued at approximately $1,822,542. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Daniel D. Woodland sold 15,000 shares of Entegris stock in a transaction dated Wednesday, July 3rd. The shares were sold at an average price of $140.00, for a total value of $2,100,000.00. Following the transaction, the insider now directly owns 37,457 shares in the company, valued at $5,243,980. The disclosure for this sale can be found here. Insiders sold a total of 68,810 shares of company stock worth $9,605,115 in the last three months. 0.67% of the stock is currently owned by company insiders.

Analyst Ratings Changes

ENTG has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Entegris from $160.00 to $145.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. BMO Capital Markets dropped their price objective on Entegris from $160.00 to $145.00 and set an “outperform” rating for the company in a research note on Thursday, August 1st. Mizuho raised Entegris from a “neutral” rating to an “outperform” rating and set a $143.00 price objective for the company in a research note on Thursday, August 1st. Finally, Needham & Company LLC reissued a “buy” rating and set a $150.00 price objective on shares of Entegris in a research note on Thursday, August 1st. One research analyst has rated the stock with a sell rating, two have given a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $146.80.

Entegris Profile

Entegris, Inc develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. It operates in three segments: Materials Solutions (MS); Microcontamination Control (MC); and Advanced Materials Handling (AMH).